Table 3.

Multivariable analysis of associations of baseline characteristics and clinical outcomes

Characteristic	No.	OS			DFS
		Adjusted HR*	95% CI	P*	Adjusted HR*	95% CI	P*
Sex
Male	65	Ref		.005	Ref		.008
Female	45	0.37	0.18-0.74		0.41	0.21-0.79
Donor type
MRD	51	Ref		<.001	Ref		<.001
MUD 10/10	44	1.43	0.70-2.95		2.38	1.21-4.68
mMUD	15	8.32	3.47-19.93		6.30	2.69-14.74
MF
Primary	58	Ref		.094	Ref		.024
Secondary	52	0.56	0.29-1.10		0.48	0.26-0.91
Cytogenetics
Favorable	67	Ref		.001	Ref		.008
Unfavorable	24	2.31	1.05-5.07		1.39	0.66-2.94
VHR	15	4.19	1.93-9.13		3.14	1.53-6.47
MIPSS70+ v2.0 classification†
Intermediate risk	11	0.29	0.04-2.26	<.001	0.24	0.03-1.91	<.001
High risk	47	Ref			Ref
VHR	35	5.05	2.39-10.70		3.87	1.90-7.88

^*Based on the multivariable Cox regression model adjusting for sex, donor type, and cytogenetics.

^†Based on the multivariable Cox regression model adjusting for sex and donor type, but not for cytogenetics.